VRTX
VERTEX PHARMACEUTICALS INC / MA
Pharmaceutical PreparationsNasdaqLarge accelerated filer
Total Trades
249
Buys
0
Sells
208
Largest Trade
N/A
Insiders
21
Institutional Funds
1,482
Inst. Value
$1M+
Activist Filings
12
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Biller Jonathan | EVP and Chief Lega… | SELL | $100K–$500K | 999 | $461.66 | Oct 3, 2024 |
| SACHS BRUCE I | Director | SELL | $1M+ | 5K | $508.00 | Aug 2, 2024 |
| SACHS BRUCE I | Director | EXERCISE | $500K+ | 5K | $125.71 | Aug 2, 2024 |
| Kewalramani Reshma | CEO & President | SELL | $1M+ | 15K | $505.00 | Aug 1, 2024 |
| Bozic Carmen | EVP and CMO | SELL | $1M+ | 2K | $471.72 | Jun 28, 2024 |
| Bozic Carmen | EVP and CMO | SELL | $1M+ | 2K | $478.00 | Jun 13, 2024 |
| Atkinson Edward Morrow III | EVP | SELL | $1M+ | 7K | $478.00 | Jun 13, 2024 |
| WAGNER CHARLES F JR | CFO | SELL | $1M+ | 3K | $460.00 | Jun 5, 2024 |
| Tatsis Ourania | EVP | SELL | $1M+ | 2K | $460.00 | Jun 5, 2024 |
| Tatsis Ourania | EVP | SELL | $1M+ | 5K | $441.99 | Jun 3, 2024 |
| Bozic Carmen | EVP and CMO | SELL | $1M+ | 2K | $445.56 | May 31, 2024 |
| WAGNER CHARLES F JR | CFO | SELL | $1M+ | 3K | $454.79 | May 30, 2024 |
| Kewalramani Reshma | CEO & President | SELL | $500K+ | 2K | $457.00 | May 29, 2024 |
| Kewalramani Reshma | CEO & President | EXERCISE | $100K–$500K | 2K | $187.53 | May 29, 2024 |
| SACHS BRUCE I | Director | SELL | $1M+ | 7K | $448.00 | May 24, 2024 |
| SACHS BRUCE I | Director | EXERCISE | $500K+ | 7K | $93.51 | May 24, 2024 |
| Kewalramani Reshma | CEO & President | SELL | $1M+ | 15K | $447.00 | May 22, 2024 |
| Bhatia Sangeeta N. | Director | GRANT | N/A | 1K | — | May 3, 2024 |
| Bhatia Sangeeta N. | Director | SELL | $100K–$500K | 467 | $402.95 | May 3, 2024 |
| Ambrose Kristen | SVP & Chief Accoun… | SELL | $100K–$500K | 240 | $419.00 | Apr 3, 2024 |
| Tatsis Ourania | EVP | SELL | $100K–$500K | 354 | $425.70 | Feb 27, 2024 |
| Sachdev Amit | EVP Chief Patient … | SELL | $1M+ | 3K | $425.70 | Feb 27, 2024 |
| Atkinson Edward Morrow III | EVP | SELL | $100K–$500K | 883 | $425.70 | Feb 27, 2024 |
| Arbuckle Stuart A | EVP, COO | SELL | $1M+ | 5K | $425.70 | Feb 27, 2024 |
| Ambrose Kristen | SVP & Chief Accoun… | SELL | $100K–$500K | 883 | $425.70 | Feb 27, 2024 |
| ALTSHULER DAVID | EVP | SELL | $1M+ | 4K | $425.70 | Feb 27, 2024 |
| Tatsis Ourania | EVP | SELL | $100K–$500K | 360 | $421.77 | Feb 23, 2024 |
| Sachdev Amit | EVP Chief Patient … | SELL | $1M+ | 3K | $421.77 | Feb 23, 2024 |
| Atkinson Edward Morrow III | EVP | SELL | $500K+ | 1K | $421.77 | Feb 23, 2024 |
| Arbuckle Stuart A | EVP, COO | SELL | $1M+ | 4K | $421.77 | Feb 23, 2024 |
| ALTSHULER DAVID | EVP | SELL | $1M+ | 3K | $421.77 | Feb 23, 2024 |
| Tatsis Ourania | EVP | SELL | $100K–$500K | 480 | $420.79 | Feb 21, 2024 |
| Sachdev Amit | EVP Chief Patient … | SELL | $1M+ | 4K | $420.79 | Feb 21, 2024 |
| Atkinson Edward Morrow III | EVP | SELL | $100K–$500K | 801 | $420.79 | Feb 21, 2024 |
| Arbuckle Stuart A | EVP, COO | SELL | $1M+ | 5K | $420.79 | Feb 21, 2024 |
| ALTSHULER DAVID | EVP | SELL | $1M+ | 4K | $420.79 | Feb 21, 2024 |
| LEIDEN JEFFREY M | Executive Chairman | SELL | $1M+ | 9K | $419.10 | Feb 16, 2024 |
| LEIDEN JEFFREY M | Executive Chairman | SELL | $1M+ | 3K | $419.42 | Feb 14, 2024 |
| Tatsis Ourania | EVP | SELL | $100K–$500K | 314 | $420.24 | Feb 13, 2024 |
| Sachdev Amit | EVP Chief Patient … | SELL | $1M+ | 3K | $420.24 | Feb 13, 2024 |
| Biller Jonathan | EVP and Chief Lega… | SELL | $500K+ | 2K | $418.77 | Feb 13, 2024 |
| Atkinson Edward Morrow III | EVP | SELL | $100K–$500K | 913 | $420.24 | Feb 13, 2024 |
| Arbuckle Stuart A | EVP, COO | SELL | $1M+ | 4K | $420.24 | Feb 13, 2024 |
| Ambrose Kristen | SVP & Chief Accoun… | SELL | $500K+ | 1K | $420.24 | Feb 13, 2024 |
| ALTSHULER DAVID | EVP | SELL | $1M+ | 3K | $420.24 | Feb 13, 2024 |
| WAGNER CHARLES F JR | CFO | SELL | $1M+ | 3K | $405.00 | Jan 4, 2024 |
| WAGNER CHARLES F JR | CFO | SELL | $1M+ | 3K | $349.88 | Nov 21, 2023 |
| Sachdev Amit | EVP Chief Patient … | SELL | $1K–$15K | 35 | $369.92 | Nov 17, 2023 |
| ALTSHULER DAVID | EVP | SELL | $1K–$15K | 19 | $369.92 | Nov 17, 2023 |
| Bozic Carmen | EVP and CMO | SELL | $1M+ | 6K | $380.82 | Nov 16, 2023 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 1,482 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Capital World Investors | 25.5M | $1M+ | SH |
| Capital Research Global Investors | 17.3M | $1M+ | SH |
| STATE STREET CORP | 11.7M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 5.2M | $1M+ | SH |
| Capital International Investors | 4.7M | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 4.5M | $1M+ | SH |
| LOOMIS SAYLES & CO L P | 3.5M | $1M+ | SH |
| VICTORY CAPITAL MANAGEMENT INC | 3.4M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 3.2M | $1M+ | SH |
| NORGES BANK | 3.2M | $1M+ | SH |
| Clearbridge Investments, LLC | 2.9M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.9M | $1M+ | SH |
| WCM INVESTMENT MANAGEMENT, LLC | 1.1M | $1M+ | SH |
| EDGEWOOD MANAGEMENT LLC | 1.1M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 849K | $1M+ | SH |
| Assenagon Asset Management S.A. | 833K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 787K | $1M+ | SH |
| Pictet Asset Management Holding SA | 752K | $1M+ | SH |
| Swiss National Bank | 703K | $1M+ | SH |
| Legal & General Group Plc | 670K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Capital Research Global Investors
SC 13G/A · Feb 12, 2026
6.8%
17.3M shares
Capital Research Global Investors
SC 13G · May 13, 2025
5.7%
14.5M shares
SC 13G/A · Feb 13, 2025
11.2%
28.7M shares
SC 13G/A · Feb 12, 2025
3.6%
9.2M shares
Capital World Investors 95-1411037
SC 13G/A · Apr 10, 2024
10.0%
25.9M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
8.7%
22.3M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 9, 2024
8.6%
22.1M shares
SC 13G · Jan 25, 2024
8.5%
21.9M shares
Capital World Investors 95-1411037
SC 13G · Feb 13, 2023
5.0%
12.9M shares
SC 13G · Jan 24, 2023
9.4%
24.2M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
2.1%
5.4M shares
SC 13G/A · Feb 1, 2022
9.4%
23.9M shares